Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis
- PMID: 35320497
- DOI: 10.1007/s12072-022-10319-6
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis
Abstract
Objective: Several studies have documented a relationship between non-alcoholic fatty liver disease (NAFLD) and structural heart disease, particularly diastolic function. This meta-analysis will be the first to examine the echocardiographic-derived cardiac function and structural characteristics in NAFLD patients, and its association with liver disease severity and metabolic profile.
Methods: Medline and Embase were searched and pairwise meta-analysis was conducted in DerSimonian and Laird to obtain the odds ratio (OR) and mean difference (MD) for dichotomous and continuous variables, respectively, to compare the effects of NAFLD on the echocardiography parameters.
Results: Forty-one articles involving 33,891 patients underwent echocardiography. NAFLD patients had worse systolic indices with lower ejection fraction (EF, MD: - 0.693; 95% CI: - 1.112 to - 0.274; p = 0.001), and worse diastolic indices with higher E/e' (MD: 1.575; 95% CI: 0.924 to 2.227; p < 0.001) compared to non-NAFLD patients. NAFLD patients displayed increased left ventricular mass (LVM, MD: 34.484; 95% CI: 26.236 to 42.732; p < 0.001) and epicardial adipose thickness (EAT, MD: 0.1343; 95% CI: 0.055 to 0.214; p = 0.001). An increased severity of NAFLD was associated with worse diastolic indices (decreased E/A ratio, p = 0.007), but not with systolic indices.
Conclusions: NAFLD is associated with impaired systolic and diastolic function with changes in cardiac structure. Concomitant metabolic risk factors and liver disease severity are independently associated with worsening systolic and diastolic function.
Keywords: Diastolic dysfunction; Diastolic indices; Echocardiography; Epicardial adipose thickness; Liver disease severity; Metabolic profile; Non-alcoholic fatty liver disease; Structural heart disease; Systolic dysfunction; Systolic indices.
© 2022. Asian Pacific Association for the Study of the Liver.
Similar articles
-
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.J Hepatol. 2018 Apr;68(4):764-772. doi: 10.1016/j.jhep.2017.11.023. Epub 2017 Nov 24. J Hepatol. 2018. PMID: 29175242
-
Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.Diabetes Metab J. 2020 Apr;44(2):267-276. doi: 10.4093/dmj.2019.0001. Epub 2019 Feb 28. Diabetes Metab J. 2020. PMID: 30877708 Free PMC article.
-
A Study of Left Ventricular Dysfunction in Normotensive Non Diabetic Patients with Non Alcoholic Fatty Liver Disease.J Assoc Physicians India. 2022 Apr;70(4):11-12. J Assoc Physicians India. 2022. PMID: 35443385
-
Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis.BMJ Open Diabetes Res Care. 2023 Feb;11(1):e003198. doi: 10.1136/bmjdrc-2022-003198. BMJ Open Diabetes Res Care. 2023. PMID: 36807034 Free PMC article.
-
Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis.Dig Liver Dis. 2018 Nov;50(11):1166-1175. doi: 10.1016/j.dld.2018.09.004. Epub 2018 Sep 20. Dig Liver Dis. 2018. PMID: 30292566
Cited by
-
Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice.Am J Physiol Gastrointest Liver Physiol. 2024 Apr 1;326(4):G385-G397. doi: 10.1152/ajpgi.00104.2023. Epub 2024 Jan 22. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38252682 Free PMC article.
-
Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis.World J Hepatol. 2025 May 27;17(5):105706. doi: 10.4254/wjh.v17.i5.105706. World J Hepatol. 2025. PMID: 40501478 Free PMC article.
-
NASH triggers cardiometabolic HFpEF in aging mice.Geroscience. 2024 Oct;46(5):4517-4531. doi: 10.1007/s11357-024-01153-9. Epub 2024 Apr 17. Geroscience. 2024. PMID: 38630423 Free PMC article.
-
Association of steatotic liver disease with all-cause and cardiovascular mortality among prehypertensive or hypertensive patients.J Glob Health. 2025 Jan 17;15:04003. doi: 10.7189/jogh.15.04003. J Glob Health. 2025. PMID: 39819662 Free PMC article.
-
Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality.Diabetes Metab J. 2025 Jan;49(1):80-91. doi: 10.4093/dmj.2024.0042. Epub 2024 Aug 28. Diabetes Metab J. 2025. PMID: 39197834 Free PMC article.
References
-
- Muthiah MD, Sanyal AJ. Burden of disease due to nonalcoholic fatty liver disease. Gastroenterol Clin North Am 2020;49(1):1–23 - DOI
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64(1):73–84 - DOI
-
- Muthiah MD, Cheng Han N, Sanyal AJ. A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know. Diabetes Obes Metab 2021;24(2):3–14
-
- Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2021;18(4):223–238 - DOI
-
- Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67(1):328–357 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical